InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.14
(
0.00%
)
Bitcoin
62,933.84
(
-0.70%
)
Post# of 43362
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Fezziwig2008

Send PM Follow Ignore
Followers 24
Posts 501
Boards Moderated 1
Alias Born 03/09/2014

Fezziwig2008

Re: None

Tuesday, 10/13/2020 7:43:01 PM

Tuesday, October 13, 2020 7:43:01 PM

Post# of 43362
LLY Monoclonal Antibody + Remidesivir Halted on Safety- - Helps $HGEN’s BET trial case- “Lilly’s ACTIV-3 trial is intended to test a monoclonal antibody developed in partnership with Gilead Sciences' remdesivir, an antiviral drug granted emergency use authorization by the U.S. Food and Drug Administration to treat COVID-19 infections”

https://www.actionnewsjax.com/news/trending/eli-lilly-pauses-late-stage-covid-19-antibody-treatment-trial-amid-safety-concerns/V3LLTEPZNBEDDADEBWFZFH7Q5Y/?outputType=amp
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up